Skip to main content
CivicGate

← Organizations

Kountoupes Denham Carr & Reid, LLC

lobbying firm

Kountoupes Denham Carr & Reid, LLC's federal footprint as a lobbying firm — reported lobbying it billed or handled on behalf of the clients it represents (this is the firm's reported revenue for that work, not its own spending). Figures are as reported to the U.S. Senate (LDA).

Lobbying from Senate LDA

Reported lobbying billed / handled $48,270,000
Firm activeFY2022–FY2025

Reported country: 🇺🇸 United States

Lobbying over time

Reported lobbying for Kountoupes Denham Carr & Reid, LLC per filing year
FYLobbying billed / handled (as firm)
2022$11,630,000
2023$11,570,000
2024$11,540,000
2025$13,530,000

Reported lobbying revenue for the clients Kountoupes Denham Carr & Reid, LLC represents — not the firm's own spending.

Clients represented

  • Optimum Communications (Formerly Reporting As Altice USA, INC.) $1,280,000 · 16 filings
  • America'S Health Insurance Plans (Ahip) $1,280,000 · 16 filings
  • Kinder Morgan, INC. $1,240,000 · 16 filings
  • Philips North America LLC (Formerly Reporting As Philips Healthcare/Holding) $1,150,000 · 16 filings
  • Cvs Health $1,120,000 · 16 filings
  • Pinterest INC. $1,050,000 · 15 filings
  • Cencora INC. (Formerly Amerisourcebergen Corporation) $1,020,000 · 17 filings
  • Fuels America $970,000 · 16 filings
  • Longi Solar Technology (Us) INC. $970,000 · 16 filings
  • Chevron Phillips Chemical Company Lp $970,000 · 15 filings

Clients Kountoupes Denham Carr & Reid, LLC filed lobbying for, by reported amount billed/handled.

Issues

Issue area Worked
Taxation/Internal Revenue Code 298
Health Issues 290
Energy/Nuclear 225
Budget/Appropriations 208
Trade (domestic/foreign) 105
Telecommunications 87
Labor Issues/Antitrust/Workplace 82
Pharmacy 79
Medicare/Medicaid 70
Transportation 70
Financial Institutions/Investments/Securities 64
Consumer Issues/Safety/Products 61
Defense 59
Science/Technology 58
Computer Industry 50
Environment/Superfund 48
Natural Resources 35
Food Industry (safety, labeling, etc.) 33
Travel/Tourism 30
Agriculture 28
Insurance 26
Veterans 24
Economics/Economic Development 22
Manufacturing 17
Automotive Industry 16
Banking 16
Chemicals/Chemical Industry 16
Government Issues 16
Sports/Athletics 16
Waste (hazardous/solid/interstate/nuclear) 16

Issue areas across Kountoupes Denham Carr & Reid, LLC's filings, by activity count. Linked areas open the CivicGate issue page.

What they lobbied on

Reported activity from Senate LDA

  • FY2025 Medicare/Medicaid

    Issues related to clinical laboratories and reimbursement for clinical laboratory services.

  • FY2025 Financial Institutions/Investments/Securities

    Issues related to interchange fees.

  • FY2025 Environment/Superfund

    Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.

    S.J.Res. 14 H.J.Res. 38

  • FY2025 Energy/Nuclear

    General education about the company including transmission, permitting, service territory demand, and pricing.

  • FY2025 Environment/Superfund

    General education about the company including transmission, permitting, service territory demand, and pricing.

  • FY2025 Energy/Nuclear

    Issues related to the implementation of the Inflation Reduction Act (Public Law 117-169), focusing on energy technologies. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024, and a House discussion draft to amend the National Environmental Policy Act of 1969.

    S. 4753

  • FY2025 Environment/Superfund

    Issues related to the implementation of the Inflation Reduction Act (Public Law 117-169), focusing on energy technologies. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024, and a House discussion draft to amend the National Environmental Policy Act of 1969.

    S. 4753

  • FY2025 Taxation/Internal Revenue Code

    Issues related to the implementation of the Inflation Reduction Act (Public Law 117-169), focusing on energy technologies.

Show 52 more activities

  • FY2025 Pharmacy

    Issues related to pharmaceutical supply chains and patient access.

  • FY2025 Medicare/Medicaid

    Issues related to Medicare Part D, Medicare Advantage and Medicaid.

  • FY2025 Insurance

    Issues related to employer, small group, and individual insurance markets.

  • FY2025 Health Issues

    Issues related to telehealth and remote patient monitoring.

  • FY2025 Energy/Nuclear

    Issues related to carbon emissions from the power sector and promoting the deployment of carbon capture technology.

  • FY2025 Energy/Nuclear

    Issues related to the Renewable Fuel Standard (RFS), including renewable volume obligation (RVO), Renewable Identification Numbers (RINs), and small refinery exemptions (SREs). Issues related to the role of biofuels in addressing domestic energy security. Issues related to SAF. Issues related to year-round sale of E15.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to the 45Z tax credit in the One Big Beautiful Bill Act (Public Law 119-21).

  • FY2025 Pharmacy

    Issues related to pharmaceutical supply chains.

  • FY2025 Medicare/Medicaid

    Issues related to Medicare Part D, Medicare Advantage and Medicaid.

  • FY2025 Insurance

    Issues related to employer, small group, and individual insurance markets.

  • FY2025 Law Enforcement/Crime/Criminal Justice

    Issues related to automatic criminal record clearance.

  • FY2025 Automotive Industry

    Issues related to clean energy technology. Issues related to autonomous vehicles.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to corporate taxation, including the One Big Beautiful Bill Act (Public Law 119-21).

  • FY2025 Trade (domestic/foreign)

    Issues related to international trade and competitiveness, including tariffs that affect the auto industry.

  • FY2025 Science/Technology

    Issues related to transportation technologies focusing on clean energy and safer vehicles. Issues related to H.R.979/S.315 AM Radio for Every Vehicle Act of 2025.

    H.R. 979 S. 315

  • FY2025 Financial Institutions/Investments/Securities

    Issues related to financial services and economic policy.

  • FY2025 Health Issues

    Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including S.1173/H.R. 2199, The Restore Protections for Dialysis Patients Act.

    S. 1173 H.R. 2199

  • FY2025 Taxation/Internal Revenue Code

    Issues related to corporate taxation.

  • FY2025 Trade (domestic/foreign)

    Issues related to global trade and supply chains.

  • FY2025 Health Issues

    Issues related to the health care supply chain.

  • FY2025 Food Industry (safety, labeling, etc.)

    Issues related to food traceability and related regulatory requirements.

  • FY2025 Trade (domestic/foreign)

    Issues related to the role of global data standards in trade facilitation, customs clearance, and supply chain.

  • FY2025 Pharmacy

    Issues related to the pharmaceutical supply chain.

  • FY2025 Consumer Issues/Safety/Products

    Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).

    H.R. 2853

  • FY2025 Science/Technology

    Issues related to privacy, content modernization, AI, and online safety.

  • FY2025 Telecommunications

    Issues related to privacy, content modernization, AI, and online safety.

  • FY2025 Health Issues

    Issues related to End-Stage Renal Disease, dialysis treatment, and coordinated care, including H.R. 2199, The Restore Protections for Dialysis Patients Act.

    H.R. 2199

  • FY2025 Health Issues

    Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.

  • FY2025 Medicare/Medicaid

    Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.

  • FY2025 Health Issues

    Issues related to supplemental health insurance and Family and Medical Leave.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to corporate taxation, including the One Big Beautiful Act (Public Law 119-21).

  • FY2025 Labor Issues/Antitrust/Workplace

    Issues related to paid leave and retirement savings.

  • FY2025 Veterans

    Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to consumer medical devices.

  • FY2025 Health Issues

    Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.

  • FY2025 Energy/Nuclear

    Issues related to the interstate natural gas pipeline industry. Issues related to pipeline safety reauthorization.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to corporate taxation and the One Big Beautiful Act (119-21).

  • FY2025 Trade (domestic/foreign)

    Issues related to trade and tariffs and impacts to the natural gas pipeline industry.

  • FY2025 Consumer Issues/Safety/Products

    Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.

  • FY2025 Health Issues

    Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.

  • FY2025 Pharmacy

    Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.

  • FY2025 Budget/Appropriations

    Issues related to the Fiscal Year 2026 Agriculture-Food and Drug Administration Appropriations bills.

  • FY2025 Energy/Nuclear

    Issues affecting the nuclear fuel supply chain. Issues regarding the U.S. Department of Energy programs to increase domestic enrichment of nuclear fuel. Issues related to nuclear energy in the One Big Beautiful Bill Act (Public Law 119-21).

  • FY2025 Consumer Issues/Safety/Products

    Issues impacting the franchise industry, including the Federal Trade Commission's Franchise Rule.

  • FY2025 Labor Issues/Antitrust/Workplace

    Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.

    H.R. 5267

  • FY2025 Science/Technology

    Issues related to online safety and data privacy.

  • FY2025 Telecommunications

    Issues related to online safety and data privacy.

  • FY2025 Health Issues

    Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.

  • FY2025 Medicare/Medicaid

    Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to corporate taxation.

  • FY2025 Trade (domestic/foreign)

    Issues related to supply chains, ports and trade policy.

  • FY2025 Labor Issues/Antitrust/Workplace

    Issues related to the retail workforce.

  • FY2025 Financial Institutions/Investments/Securities

    Financial services, payments, competition.

The specific issues and bills Kountoupes Denham Carr & Reid, LLC reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.